Showing results (51-60 of 447) with videos related to
Sort By:
Pageof 45
Cardio-Oncology (London, England)|September 5, 2024
Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD - PILOT trialAndrés J Daniele, Vanesa Gregorietti, Diego Costa, et al.Cardio-Oncology (London, England)|May 17, 2024
Formative research to adapt a cardiac rehabilitation program to breast cancer survivors: the heart health after cancer treatment (HEART-ACT) studyAlison Chang, Alisa Boyd, Ivan Leung, et al.Cardio-Oncology (London, England)|September 25, 2023
Cardiovascular adverse events of antineoplastic monoclonal antibodies among cancer patients: real-world evidence from a tertiary healthcare systemAbdulrazaq S Al-Jazairi, Nahlah Bahammam, Dhai Aljuaid, et al.Cardio-Oncology (London, England)|September 20, 2023
Complete heart block is a significant predictor of mortality in immune checkpoint inhibitor myocarditisMichael P O'Shea, Suganya Arunachalam Karikalan, Ali Yusuf, et al.Cardio-Oncology (London, England)|July 10, 2023
Simultaneous exercise stress cardiac magnetic resonance and cardiopulmonary exercise testing to elucidate the Fick components of aerobic exercise capacity: a feasibility and reproducibility study and pilot study in hematologic cancer survivorsJustin M Canada, John McCarty, Jennifer H Jordan, et al.Cardio-Oncology (London, England)|July 7, 2023
Cardiovascular toxicities after anthracycline and VEGF-targeted therapies in adolescent and young adult cancer survivorsJeannette R Wong-Siegel, Robert J Hayashi, Randi Foraker, et al.Cardio-Oncology (London, England)|March 20, 2020
A case report: high dose melphalan as a conditioning regimen for multiple myeloma induces sinus arrestLiang-Liang Ma, Ying Liu, Si-Xun Jia, et al.Cardio-Oncology (London, England)|March 11, 2020
Cardiac events during treatment with proteasome inhibitor therapy for multiple myelomaJohn H Chen, Daniel J Lenihan, Sharon E Phillips, et al.Cardio-Oncology (London, England)|March 11, 2020
Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case seriesSarju Ganatra, Anju Nohria, Sachin Shah, et al.Cardio-Oncology (London, England)|March 11, 2020
Systemic and cardiac susceptibility of immune compromised mice to doxorubicinAmanda J Favreau-Lessard, Hagen Blaszyk, Michael A Jones, et al.Pageof 45